ProMIS Neurosciences Inc. (PMN) stock: key figures, P/E, revenue and dividend
Health Care · Canada · ISIN CA74346M5054
ProMIS Neurosciences Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -40.17 m USD |
| EBIT | -39.72 m USD |
| Net income | -39.72 m USD |
| Diluted EPS – continuing operations | -22.61 USD |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ProMIS Neurosciences Inc.
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for the treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.
More stocks
- JONES SODA CO. (JSDA)
- SEAFARER EXPLORATION CORP (SFRX)
- RAVE RESTAURANT GROUP, INC. (RAVE)
- Paradium AI, Inc. (PAAI)
- HARTE HANKS INC (HHS)
- BriaCell Therapeutics Corp. (BCTX)
- RYTHM, Inc. (RYM)
- Quest Resource Holding Corp (QRHC)
- Kestrel Group Ltd (KG)
- Grandstand Limited (GRSD)
- NextCure, Inc. (NXTC)
- Zhanling International Ltd (ZLME)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.